President Donald Trump announced the withdrawal of Dr. Casey Means’ nomination to serve as U.S. Surgeon General and will instead nominate Dr. Nicole Saphier, a board-certified radiologist and Director of Breast Imaging at Memorial Sloan Kettering Cancer Center who also serves as a longtime Fox News medical contributor.

Why did the President withdraw Dr. Means’ nomination, and what does this mean for public health and the MAHA agenda?

Casey Means, 38, is a Stanford University School of Medicine graduate (M.D., 2014) who completed four years of an otolaryngology-head and neck surgery residency at Oregon Health & Science University before leaving the program in 2018. Her Oregon medical license, issued in 2018, has been listed as inactive since 2019; she has not practiced clinical medicine in any conventional capacity for years. Instead, Means co-founded Levels Health, a metabolic-health startup that sells continuous glucose monitors, and co-authored the 2024 bestseller Good Energy with her brother, Calley Means, now a senior adviser at the Department of Health and Human Services. She has built a large social-media following as a functional-medicine advocate who argues that metabolic dysfunction—driven by diet, environment, and lifestyle—is the root cause of America’s chronic-disease epidemic.

Trump nominated Dr. Casey Means on May 7, 2025, the same day he withdrew his first choice, Dr. Janette Nesheiwat, after questions surfaced about her credentials. In his Truth Social announcement, Trump praised Means’ “impeccable MAHA credentials” and stated that she would work closely with HHS Secretary Robert F. Kennedy Jr. to reverse the chronic disease epidemic. The selection aligned perfectly with the administration’s “Make America Healthy Again” narrative. Means had served as an adviser to Kennedy during his 2024 presidential campaign and embodied the movement’s outsider critique of Big Food, Big Pharma, and a medical system that, in her view, treats symptoms rather than root causes. Her personal story—leaving traditional residency because she viewed the system as exploitative—resonated with voters frustrated by annual U.S. healthcare spending exceeding $4.8 trillion, adult obesity rates around 42 percent, and more than 40 million Americans living with diabetes.

Why Did Trump Withdraw Dr. Casey Means’ Nomination?

The Means nomination , was advanced in May 2025 with strong support from HHS Secretary Robert F. Kennedy Jr., stalled for nearly 11 months in the Senate Health, Education, Labor and Pensions (HELP) Committee. Senators from both parties expressed concerns about her lack of an active medical license since 2019, her incomplete residency training and her public positions on vaccines and chronic disease.

Despite initial momentum, the nomination never gained meaningful traction. Following a tense Senate HELP Committee hearing in late February 2026, progress ground to a halt. Several Republican senators, including Lisa Murkowski of Alaska and Susan Collins of Maine, voiced reservations. Committee Chairman Bill Cassidy, a practicing physician, pressed Means on vaccine policy. She emphasized informed consent and patient autonomy but stopped short of the unequivocal public endorsement senators expected from the nation’s top doctor.

Former Surgeon General Jerome Adams publicly opposed the nomination, arguing that the leader of the 6,000-member U.S. Public Health Service Commissioned Corps should meet the same clinical and licensure standards required of the officers she would command. Means’ inactive license and unfinished residency became central flashpoints. Critics pointed out that although she had seen patients during training and briefly in a functional-medicine setting, she had not maintained the active licensure or board certification typical of previous surgeons general.

The failure was not driven by ideology alone. Even with Republican majorities, individual senators — many of them physicians — insisted on operational credibility for a position that demands the ability to deliver evidence-based guidance during crises and oversee a uniformed service. After nearly a year of delays, repeated questioning, and quiet signals from the HELP Committee, it became clear that Means lacked the votes to advance. The White House’s pivot to Dr. Nicole Saphier, a board-certified radiologist with an active clinical practice and strong communication skills, indicates that the administration recognizing that messaging may be stronger from a physician whose credentials command broad respect.

Who Is Dr. Nicole Saphier?

Dr. Nicole Saphier is a board-certified radiologist and Director of Breast Imaging at Memorial Sloan Kettering Cancer Center Monmouth, where she also serves as an associate professor of radiology at Weill Cornell Medicine. A graduate of Ross University School of Medicine, she completed her radiology residency at Maricopa Integrated Health Systems and advanced fellowship training at the Mayo Clinic. With deep expertise in oncologic imaging and women’s health, Saphier has spent her clinical career guiding patients through complex cancer diagnoses, with a strong emphasis on early detection and prevention. She is also a former longtime Fox News medical contributor (2018–2026).

What Does This Mean For The MAHA Movement?

Make America Healthy Again (MAHA) is a national health reform movement led by Robert F. Kennedy Jr. and supported by the Trump administration that seeks to reverse America’s chronic disease epidemic by addressing root causes rather than just treating symptoms.

MAHA focuses on three core pillars: overhauling the nation’s food system to reduce ultra-processed foods and seed oils, decreasing exposure to environmental toxins and harmful chemicals and restoring integrity and transparency to federal health agencies such as the FDA, CDC, and USDA.

The movement emphasizes personal responsibility, metabolic health, disease prevention, and a return to evidence-based public health policy that prioritizes nutrition, lifestyle, and environmental factors over pharmaceutical-centric approaches.

This episode reveals a tension within the MAHA movement. Reforming a $4.8 trillion system that produces mediocre outcomes demands bold ideas and outsiders willing to challenge entrenched interests. Yet the Surgeon General is not a podcast host or startup founder; it is a statutory office whose occupant must lead uniformed officers, brief presidents in emergencies, and speak with authority that transcends partisan lines. Physicians understand this instinctively: credentials are not elitism—they are the hard-earned signal that someone has walked the wards, managed complications, and accepted liability for decisions that affect real patients.

America still lacks a confirmed Surgeon General more than 15 months into the administration. Chronic disease continues its relentless climb. The free market of ideas worked here: scrutiny exposed gaps, senators exercised independent judgment and the White House course-corrected. Whether the next nominee can unify Republicans, reassure the public and earn confirmation will determine if the nation gets the credible public-health leadership it needs.